Patents by Inventor Tamar Paz-Elizur

Tamar Paz-Elizur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180119227
    Abstract: Methods and kits for determining a risk of a subject, or subjects for developing lung cancer is disclosed. The method comprises determining a level of catalytic activity of N-methylpurine DNA glycosylase (MPG), or apurinic/apyrimidinic endonuclease 1 (APE1), or both, or MPG and 8-oxoguanine DNA glycosylase (OGG1), or MPG and APE1 and OGG1 in peripheral blood cells of a subject, wherein levels of MPG above a predetermined reference value, or APE1 or OGG1, or a integrated DNA repair score below a predetermined reference value is indicative of an increased risk of developing lung cancer.
    Type: Application
    Filed: October 4, 2017
    Publication date: May 3, 2018
    Applicant: Yeda Research and Development Co. Ltd.
    Inventors: Zvi LIVNEH, Tamar PAZ-ELIZUR
  • Publication number: 20140248293
    Abstract: Methods and kits for determining a risk of a subject, or subjects for developing lung cancer is disclosed. The method comprises determining a level of catalytic activity of N-methylpurine DNA glycosylase (MPG), or apurinic/apyrimidinic endonuclease 1 (APE1), or both, or MPG and 8-oxoguanine DNA glycosylase (OGG1), or MPG and APE1 and OGG1 in peripheral blood cells of a subject, wherein levels of MPG above a predetermined reference value, or APE1 or OGG1, or a integrated DNA repair score below a predetermined reference value is indicative of an increased risk of developing lung cancer.
    Type: Application
    Filed: September 6, 2012
    Publication date: September 4, 2014
    Applicant: Yeda Research and Development Co., Ltd
    Inventors: Zvi Livneh, Tamar Paz-Elizur
  • Publication number: 20110294134
    Abstract: Methods and kits for (i) determining a risk of a subject to develop cancer; (ii) evaluating an effectiveness and dosage of cancer therapy administered to a cancer patient; and (iii) determining a presence of correlation or non-correlation between an activity of at least one DNA repair enzyme and at least one cancer, are disclosed.
    Type: Application
    Filed: August 8, 2011
    Publication date: December 1, 2011
    Applicant: YEDA RESEARCH AND DEVELOPMENT CO., LTD.
    Inventors: ZVI LIVNEH, TAMAR PAZ-ELIZUR, SARA BLUMENSTEIN
  • Patent number: 8043807
    Abstract: Methods and kits for (i) determining a risk of a subject to develop cancer; (ii) evaluating an effectiveness and dosage of cancer therapy administered to a cancer patient; and (iii) determining a presence of correlation or non-correlation between an activity of at least one DNA repair enzyme and at least one cancer, are disclosed.
    Type: Grant
    Filed: March 21, 2002
    Date of Patent: October 25, 2011
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Zvi Livneh, Tamar Paz-Elizur, Sara Blumenstein
  • Patent number: 7970547
    Abstract: A device, system and method for molecular computing which not only includes a suitable, renewable power source, but actually is able to receive power through the performance of the computations themselves. The molecular computing machine of the present invention actually employs the free-energy difference between its input and output to accomplish a computation, preferably by using its input DNA molecule as a partial source of energy, or alternatively by using the input DNA molecule as the sole source of energy. This molecular finite automaton preferably transforms an input DNA molecule into an output DNA molecule by digesting the input as it computes.
    Type: Grant
    Filed: November 14, 2002
    Date of Patent: June 28, 2011
    Assignee: Yeda Research and Development Co. Ltd.
    Inventors: Ehud Shapiro, Yaakov Benenson, Rivka Adar, Tamar Paz-Elizur
  • Publication number: 20050075792
    Abstract: A device, system and method for molecular computing which not only includes a suitable, renewable power source, but actually is able to receive power through the performance of the computations themselves. The molecular computing machine of the present invention actually employs the free-energy difference between its input and output to accomplish a computation, preferably by using its input DNA molecule as a partial source of energy, or alternatively by using the input DNA molecule as the sole source of energy. This molecular finite automaton preferably transforms an input DNA molecule into an output DNA molecule by digesting the input as it computes.
    Type: Application
    Filed: November 14, 2002
    Publication date: April 7, 2005
    Inventors: Ehud Shapiro, Yaakov Benenson, Rivka Adar, Tamar Paz-Elizur
  • Publication number: 20040096863
    Abstract: Methods and kits for (i) determining a risk of a subject to develop cancer; (ii) evaluating an effectiveness and dosage of cancer therapy administered to a cancer patient; and (iii) determining a presence of correlation or non-correlation between an activity of at least one DNA repair enzyme and at least one cancer, are disclosed.
    Type: Application
    Filed: September 16, 2003
    Publication date: May 20, 2004
    Inventors: Zvi Livneh, Tamar Paz-Elizur, Sara Blumenstein
  • Publication number: 20030003454
    Abstract: Methods and kits for (i) determining a risk of a subject to develop cancer; (ii) evaluating an effectiveness and dosage of cancer therapy administered to a cancer patient; and (iii) determining a presence of correlation or non-correlation between an activity of at least one DNA repair enzyme and at least one cancer, are disclosed.
    Type: Application
    Filed: March 23, 2001
    Publication date: January 2, 2003
    Applicant: Yeda Research and Development Co. Ltd. at The Weizmann Institute of Science
    Inventors: Zvi Livneh, Tamar Paz-Elizur, Sara Blumenstein